Q&As on conditions of supply for rapid antigen point of care COVID-19 tests

Name: Q&As on conditions of supply for rapid antigen point of care COVID-19 tests
Creator: Therapeutic Goods Administration
Keywords: coronavirus,covid,covid-19,faq,frequently-asked-questions,guidances,point-of-care,rapid-antigen,sars-cov-2,supplying

Information

Original link

Type

Guidance

Regulated products

Medical Devices

Topics

COVID

Published

May 16, 2024

Last updated

May 16, 2024

Description

Answers to frequently asked questions in relation to rapid antigen point-of-care tests.

Organization

Therapeutic Goods Administration (TGA) 🇦🇺

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

1 Main file

Q&As on conditions of supply for rapid antigen point of care COVID-19 tests

Updated on May 16, 2024

html

URL: https://www.tga.gov.au/resources/resource/guidance/qas-conditions-supply-rapid-antigen-point-care-covid-19-tests
Permalink: https://data.openrid.co/en/datasets/r/1de047b2-bc9d-410d-b2b6-7beda1874fe4
MIME Type: text/html

Created on: May 16, 2024
Modified on: May 16, 2024

Q&As on conditions of supply for rapid antigen point of care COVID-19 tests

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed